Skip to main content

Viracta Therapeutics, Inc.

VIRXDelisted Jul 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001061027

Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Viracta Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of VIRX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders6869+1
Shares15.5M14.2M−1.33M (−8.6%)
Value$124.6M$51.8M−$72.9M (−58.5%)

New holders (13)

Institutions that held Viracta Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to VIRX in Q4 2021
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP159,331$582.0K0.00%
Renaissance Technologies LLC115,700$422.0K0.00%
Allspring Global Investments Holdings, LLC73,011$266.0K0.00%
Ensign Peak Advisors, Inc60,515$221.0K0.00%
Two Sigma Advisers, LP48,144$176.0K0.00%
Occudo Quantitative Strategies LP32,651$119.0K0.01%
Susquehanna International Group, LLP29,358$107.0K0.00%
Marshall Wace, LLP29,001$106.0K0.00%
Federated Hermes, Inc.28,582$104.0K0.00%
Engineers Gate Manager LP17,081$62.0K0.00%
ProShare Advisors LLC13,174$49.0K0.00%
Cubist Systematic Strategies, LLC11,960$44.0K0.00%
Simplex Trading, LLC474$1.00K0.00%

Sold out (12)

Institutions that held Viracta Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of VIRX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Adams Street Partners LLC729,509$5.85M
Opaleye Management Inc.258,556$2.07M
Janus Henderson Group PLC249,686$2.00M
Blackstone Group Inc.238,542$1.91M
Bailard, Inc.50,000$401.0K
Oppenheimer & Co Inc38,037$305.0K
NEA Management Company, LLC37,093$297.0K
Palo Alto Investors LP33,212$266.0K
SG Americas Securities, LLC20,454$164.0K
Metropolitan Life Insurance Co5,766$46.2K
MetLife Investment Management5,069$40.7K
Brewin Dolphin Ltd749$6.01K